Metallothionein-3 (MT3), a brain-specific metalloprotein, serves as a primary antioxidant that rapidly responds to oxidative stress
Similarly, tirzepatide, a dual GLP-1/GIP receptor agonist, demonstrated impressive results in the SYNERGY-NASH trial, with a high percentage (74%) of participants achieving an absence of NASH and no worsening of fibrosis
Some side effects may be easy to manage
Life without glutathione is impossible
Headache: Headaches are relatively common among users of GLP-1 medications, although they are generally mild and manageable
Understanding iron metabolism is also important for understanding diseases of iron overload, such as hereditary hemochromatosis, and iron deficiency, such as iron-deficiency anemia